Compositions for clinical complications associated to devices implanted in the urinary tract
AssigneesDevicare SL, Universidad De Les Illes Balears
InventorsFelix Grases Freixedas, Jordi Cuñe Castellana, Antonia Costa-Bauzá, Paula Calvó García, Sebastián Albertí Serrano, Margalida Mateu Borrás
Life of this patent
Estimating the term…
Abstract
It is provided a composition comprising phytic acid or a pharmaceutically acceptable salt thereof, for use in reducing or preventing microorganisms' proliferation and/or encrustations caused by a urinary tract device implanted in a subject, thereby preventing or treating clinical complications related to microorganisms' proliferation and/or encrustations. The composition can further comprise a urine acidifier such as methionine, a crystallization inhibitor such as theobromine and/or other agents.
Claims20
A method of preventing or treating at least one clinical complication related to microorganisms' proliferation and/or encrustations in a subject in need thereof comprising orally administering to the subject a composition comprising phytic acid or a pharmaceutically acceptable salt thereof, wherein the microorganisms' proliferation and/or encrustations are caused by a urinary tract device implanted in the subject, and wherein the oral administration of the composition prevents or treats at least one clinical complication related to the microorganisms' proliferation and/or encrustations.
A method of preventing of reducing struvite encrustation on a urinary tract device implanted in a subject in need thereof comprising orally administering to the subject an effective amount of a composition comprising phytic acid or a pharmaceutically acceptable salt thereof, wherein the composition prevents or reduces struvite encrustations on the urinary tract device.
A method of preventing or treating at least one clinical complication related to microorganisms' proliferation and/or encrustations in a subject in need thereof comprising administering to the subject a composition comprising phytic acid or a pharmaceutically acceptable salt thereof in combination with theobromine, wherein the microorganisms' proliferation and/or encrustations are caused by a urinary tract device implanted in the subject, wherein the administration of the composition prevents or treats at least one clinical complication related to the microorganisms' proliferation and/or encrustations.
Dependencies are inferred from the claim text.